C10 LABS
C10 LABS is a Pre-seed, Seed and other fund in the US and New England investing in AI, Healthcare and healthcare-tech.
- Stages
- Pre-seed, Seed, other
- Sectors
- AI, Healthcare, healthcare-tech
- Invests in
- US-wide, New England
- Actively investing
- Yes
- Founded
- 2023
- Website
- c10labs.com
Check size not disclosed
Thesis
C10 Labs is an AI-native venture studio and fund established in 2023, headquartered in Cambridge, Massachusetts, with a presence in New York City. Their mission is to identify, incubate, and scale AI-first companies, operating as a venture studio that offers technological support, operational expertise, and a network of advisors. The firm invests in and incubates companies at the forefront of artificial intelligence, focusing on foundation models, vertical expert systems, agentic workflows, and AI in Bio/HealthTech. Their strategy involves partnering with researchers, technologists, and operators to build institutional-grade companies. C10 Labs engages through pre-seed/seed investments, studio build partnerships, services-for-equity commercialization, and ecosystem acceleration. They aim to solve complex problems with applied AI, fostering experimentation and commercial viability. While AUM is not disclosed, they have made at least 12 investments. They also partner with RIHub, extending their reach to Rhode Island and Southeastern New England. The firm is committed to diversity and inclusion in AI and collaborates with organizations like LabCentral and RIHub.
Common questions
Does C10 LABS invest at the Pre-seed stage?
Yes. C10 LABS lists Pre-seed, Seed and other among the stages it invests in.
Where does C10 LABS invest?
C10 LABS invests in the US and New England.